Hot flashes, broken sleep, mood changes, vaginal dryness, low libido — menopause symptoms can affect daily life, work, and relationships. Hormone therapy is one option for some women, and it comes in several forms: pills, patches, gels, sprays, vaginal products, and pellets. This post explains one form patients ask about often — pellets — including what they are, what an insertion visit is like, and the important trade-offs to understand before choosing them.
Hormone therapy replaces estrogen, with or without a progestogen, when levels fall in perimenopause and menopause. For appropriately selected women — commonly those younger than 60 or within 10 years of menopause onset, after an individual risk review — systemic hormone therapy is the most effective treatment for hot flashes and night sweats, and local vaginal estrogen helps dryness.
The right form, dose, and duration depend on your symptoms, medical history, whether you still have a uterus, and your preferences.
A pellet is a small, solid implant — a little larger than a grain of rice — placed under the skin, usually in the hip or buttock area.
Insertion is a short in-office procedure:
If symptoms return before the pellet is expected to wear off, or if new symptoms appear, contact the office rather than adding another hormone product on your own.
Patients who ask about pellets are usually women in perimenopause or menopause who:
Pellet therapy is not right for everyone. A full history is needed first — including breast cancer history, blood clots or stroke, liver disease, unexplained vaginal bleeding, and other hormone-sensitive conditions — and unexplained bleeding needs evaluation before any hormone therapy starts.
This is the part to understand clearly.
Pellets used for women are custom-compounded products. They are not FDA-approved for menopause symptoms. There is no FDA-approved estradiol pellet for women, and there is no FDA-approved testosterone product for menopausal symptoms.
ACOG — the American College of Obstetricians and Gynecologists — recommends FDA-approved hormone therapies over compounded bioidentical therapy for menopause symptoms, and states that compounded therapy should not be prescribed routinely when FDA-approved formulations exist. ACOG specifically advises against testosterone delivered by pellet, because there is limited high-quality safety data and, once placed, a pellet cannot be removed if the dose is too high or side effects occur — you have to wait for it to dissolve.
"Bioidentical" describes the chemical structure of a hormone. It does not by itself prove that a compounded product is safer, more natural, or more effective than an FDA-approved one, and claims of superiority are not supported by high-quality evidence. Compounded products can also vary in strength and absorption.
None of that makes the conversation off-limits. It means the decision should be a shared one, with those facts on the table, a comparison with FDA-approved pills, patches, gels, and vaginal options, and a clear monitoring plan if pellets are chosen.
Possible advantages patients value:
Limitations and risks to weigh:
Anyone on hormone therapy needs follow-up — symptoms, blood pressure, bleeding pattern, breast screening, and periodic re-review of whether therapy should continue, change form, or stop. Doses should be guided by symptom relief and the overall picture, not by a promise to restore hormone levels to a youthful target. Keep every follow-up appointment and report abnormal bleeding promptly.
Pellets are a long-acting, in-office way to deliver hormones for menopause symptoms — and they are also a compounded, not-FDA-approved option that cannot be taken back once placed. For many women, an FDA-approved therapy will be the recommended first choice. For others, after a careful review and an honest discussion of the evidence and the alternatives, pellets are the option they choose to discuss further.
If menopause symptoms are affecting your sleep, comfort, or quality of life, book a visit. We will review your history, explain all the hormone and non-hormone options in plain language, and make the decision together.
General patient education only. Hormone therapy decisions are individual and require a medical history review.